Luca Aldrighetti, MD, PhD, is Director of the Hepatobiliary and General Surgery Division at San Raffaele Hospital, Milan, Italy. Scientific Director of the Italian Group of Minimally Invasive Liver Surgery (IGoMILS) and Coordinator of the Italian Registry of Laparoscopic Liver Resections. Member of the Council and Chair of the Registry Committee of the International Laparoscopic Liver Society (ILLS). Primary clinical and research activities include surgical oncology topics on colorectal liver metastases, perihilar and intrahepatic cholangiocarcinoma and hepatocellular carcinoma, techniques for liver resection (including two stage hepatectomies and ALPPS procedures), and minimally invasive hepatobiliary surgery (including major hepatectomies, resection in postero-superior segments and in cirrhosis), with a personal series of more than 2900 liver resections, more than 1000 of which performed laparoscopically. He has published more than 300 papers, including many studies on techniques, learning curve and outcomes of laparoscopic liver resections. Current H index is 41. He continues with teaching and tutoring activities in a number of national and international courses in both open and laparoscopic liver surgery.

Professor, MD, PhD, Head of the Immunology Department of the University of Medicine and Pharmacy “Grigore T. Popa” Iasi, Head of the Laboratory of Immunology, “St. Spiridon” Clinical Hospital, Iasi.

Dr. Petru Cianga graduated the University of Medicine and Pharmacy “Grigore T. Popa” Iasi in 1990 and earned his PhD in Medical Sciences in 2002, with a research topic regarding a non-classical MHC. He completed several training programs in France, Germany, Belgium and USA, thus having the opportunity to work and gain expertise in various fields of immunology research.

He pursued his post-doctoral training in the University of Texas Southwestern Medical Center at Dallas, under the supervision of Dr. E Sally Ward, and thus had the possibility to collaborate and publish together with the Nobel laureate, Dr. Johann Deisenhofer.

In 2000 and 2001 he worked in the Immunohematology and Kidney Transplant Unit of the St. Luc Hospital, the division of the Université Catholique de Louvain in Brussels, under the supervision of Professor Dr. Mark de Bruyere, one the proeminant personalities of the Eurotransplant at that time. Here he had the opportunity not only to master various techniques specific to the transplantation immunology field, but also to gain insight in the kidney transplant coordination within the Eurotransplant network.

Soonafter, with the generous help of Professor Dr. Mark de Bruyere, an HLA laboratory could be created in the “St. Spiridon” Clinical Hospital, Iasi. This laboratory developed over the years and now covers all types of transplants that are currently performed in Iasi , being further involved in the management of the National Stem Cell Registry.

Dr. Duda obtained his DMD from the University of Medicine Iasi, Romania in 1993, and earned a PhD in Medical Sciences (GI Surgery) from Tohoku University Graduate School of Medicine, Sendai, Japan in 2001. After graduation, he pursued postdoctoral training with Professor Rakesh K. Jain in the Steele Laboratories for Tumor Biology, Department of Radiation Oncology, MGH and Harvard Medical School in Boston. He became a Junior Faculty member (Instructor) in 2004, and then rose through the ranks to Full Investigator at MGH Research Institute in 2016 and Associate Professor of Tumor Biology (Radiation Oncology) at Harvard Medical School in 2012. In 2016, he was appointed as the Director of Translational Research in Gastrointestinal Radiation Oncology at MGH. He has been active internationally and is currently serving as the Secretary General of the IASGO since 2015. He is a member of the AASLD Liver Fibrosis Special Interest Group. He has also been serving as a panel member for multiple scientific expert/grant review meetings worldwide since 2009, including as a permanent member of the US NCI DMP, ACS TBG, and Belgium FWO Med4 sections. He currently serves as the Chair of the FWO Med4 panel.

The research of Dr. Duda’s laboratory focuses on studies of tumor interaction with its  microenvironment, with the goal of identifying the cellular and molecular mechanisms of 1) local tumor progression (in liver cancers) and metastatic tumor progression (in other GI cancers), and 2) treatment resistance in advanced cancers. The ultimate goal is to identify and validate targets for combination therapy with radiotherapy and immunotherapy in preclinical studies, and in parallel conduct studies of biomarkers of response in correlative clinical studies.

Dr. Duda has authored over 200 publications so far, of which 121 are original reports. He has been invited to present his results at nearly 200 local, national and international meetings, including Grand Rounds, Plenary Talks and Keynote Lectures. For his work, Dr. Duda received several awards, including from the American Association for Cancer Research, Cancer Research Institute, International Association of Surgeons, Gastroenterologists and Oncologists (IASGO), MGH and the Granara-Skerry Trust for Pancreatic Cancer Research. He is an Honorary Member of the Academy of Medical Sciences of Romania since 2012.

 For more information, see: https://steelelabs.mgh.harvard.edu/dan_duda/pi_bio

MEDICAL EDUCATION

M.D. Degree

University of Belgrade, Medical Faculty, Belgrade / SERBIA (1982-1987)

Overall score: 9.93 out of 10.0

Ph.D.

University of Belgrade, Medical Faculty, Postgraduate School, Belgrade / SERBIA (1998-2000.)

PROFESSIONAL EXPERIENCE AND EMPLOYMENT

• Chief Intensive Care Unit – Department for Surgical Infection and Sepsis Clinic for Emergency Surgery, Clinical Center of Serbia Belgrade / SERBIA (1995-2004)
• Head Department of HPB Surgery – Clinic for Emergency Surgery, Clinical Center of Serbia Belgrade / SERBIA (2004-2008)
• Director – Clinic for Emergency Surgery, Clinical Center of Serbia Belgrade / SERBIA (2008-2016)
• Senior Consultant – HPB Surgery Faculty of Medicine University of Belgrade, Clinical Center of Serbia Belgrade / SERBIA (2016-2018)
• Director – Clinic for Surgery “Nikola Spasic”, University Clinical Center “Zvezdara” Belgrade / SERBIA (2018-present)

UNIVERSITY CAREER

Elected Full Professor of Surgery Faculty of Medicine University of Belgrade / SERBIA (2016-present)

SOCIETY MEMBERSHIPS

International Association of Surgeons, Gastroenterologists & Oncologists (IASGO)

Fellow of the American College of Surgeons (FACS)

European Surgical Association (ESA) Member

World Society of Emergency Surgery (WSES) – National Delegate of Serbia

REVIEWER

British Journal of Surgery

World Journal of Gastroenterology

World Journal of Surgical Oncology

World Journal of Emergency Surgery

World Journal of Hepatology

World Journal of Gastrointestinal Oncology

Radiology and Oncology

Liver Cancer

Journal of Investigative Surgery

JoVE

Digestive surgery

PUBLICATIONS

Monography: “Intra-abdominal Infections and Septic Syndrome in Abdominal Surgery”, 2002       

University Book editor: Liver Resections (with operative surgery techniques – CD), 2012

Original Articles: 100 covered by (Current Contents (CC); Science Citation Index (SCI); Pub-Med; Medline)

 INVITED LECTURER

Invited Faculty at more than 60 International and Regional Congresses and Meetings

Andrea Lauterio, MD, is a board-certified in general surgery and specialty trained in
abdominal organs transplantation and hepatobiliary surgery. His expertises lie in liver, kidney and pancreas transplantation, primary and metastatic liver cancer, and minimally invasive procedures focused on robotic surgery. He serves as an Attending Surgeon at the Division of General Surgery & Transplantation – ASST Grande Ospedale Metropolitano Milanese – Niguarda, Milan, Italy.
Dr. Lauterio was born in Italy on September 11, 1975. He graduated in Medicine and Surgery from the Milan University School of Medicine on July 21, 2000. He completed his residency in General Surgery at the University School of Medicine of Milan on November 9, 2006.
In the same year Dr. Lauterio was appointed staff surgeon in the Transplant unit of the ASST Grande Ospedale Metropolitano Milanese – Niguarda, Milan, Italy.
He received focused training on living donor liver transplantation with particular attention the surgical technique and the immunosuppressive protocols, as a Visiting Surgeon, at the University of Pittsburgh (PA), Thomas E. Starzl Transplantation Institute in 2003.
He had the opportunity to access the robotic surgical training laboratory to practice and develop skills in advanced applications of the robotic system, as a Visiting Surgeon, at the University of Illinois Hospital and Health Sciences System, Department of Surgery in 2017.
From 2015, Dr. Lauterio is a Fellow of the European Board of Surgery (F.E.B.S.), division of Transplantation.
He was participant in several sponsored international multi centres trials conducted following the ICH-GCP requirements in continuous update.
Dr. Lauterio has published in peer-reviewed professional journals such as Gastroenterology and Journal of Hepatology, and presented at major scientific conferences. Clinical interests include abdominal organ transplantation, living donor transplantation, robotic surgery, resection of primary and metastatic liver cancers, and multi-stage resection of complex liver lesions.
Dr. Lauterio’s current research involves the role of laparoscopic and robotic surgical techniques in liver surgery and kidney procurement from living donor, the new strategies in the management of hepatocellular carcinoma and liver metastases, grafts preservation, liver transplantation in HIV-positive recipients, organ donation after cardiac death, and policy issues regarding organ allocation.

Dr. Loghin joined the UTHealth McGovern Medical School in 2004. He earned his medical degree, completed his training and became faculty for the Department of Internal Medicine  of the University of Medicine and Pharmacy Gr.T. Popa Iasi, Romania. Dr. Loghin further completed his cardiology training at the UTHealth McGovern Medical School. Dr. Loghin is an expert in cardiovascular diagnostic imaging, including echocardiography, nuclear cardiology, cardiac computed tomography, cardiac magnetic resonance imaging and diagnostic catheterization. He is board certified by the American Board of Internal Medicine in Internal Medicine, Cardiovascular Diseases, Nuclear Cardiology, Cardiac Computed Tomography and Echocardiography. Dr. Loghin is a seasoned academic clinician, with more than 30 years experience in teaching cardiology trainees, and with a very large clinical practice with UT Physicians. He also serves as a reviewer for Circulation, Journal of the American Heart Association, Journal of Nuclear Medicine and American Heart Journal.

Dr. Loghin pioneered the field of interventional imaging, and participated as an investigator in seminal trials involving management of structural heart disease. He is currently responsible for developing the cardiac computed tomography service with Memorial Hermann Hospital, the main teaching facility for UTHealth McGovern Medical School.

Research Interests

Cardiac computed tomography: coronary physiology (FFR and myocardial perfusion), chest pain management using cardiac CTA techniques, imaging of complex structural heart disease.

Echocardiography: advanced diagnostic imaging of valvular heart disease, imaging planning and guidance of transcatheter interventions for complex structural heart disease.

Honors & Awards

Cardiovascular Medicine Faculty of the Year: 2009, 2010, 2011, 2012.

Dr. Loghin is an Associate Professor in the Department of Neuro-Oncology, who specializes in neurological complications of cancer treatment, with a particular interest in neurological complications of cancer and cancer therapy. She received her medical degree from Grigore T. Popa University of Medicine and Pharmacy, and graduated a clinical residency at the University of Texas Health Science Center, and a clinical fellowship at MD Anderson Hospital, Houston, USA. She joined the MD Anderson faculty in 2006. Dr. Loghin maintains a very busy clinical practice, and provides expert consultative inpatient services. She currently serves as the Department of Neuro-Oncology Residency Program Director. Dr. Loghin collaborates closely with the Neuro-psychology section in developing new therapeutic strategies for cancer-related cognitive dysfunction. As part of MDACC CARTOX Cell Therapy Group, Dr. Loghin was actively involved in developing national guidelines for asessment and management of CAR T cell induced neurotoxicity.

Meet Monica Loghin, M.D.
Present Title & Affiliation
Primary Appointment
Associate Professor, Department of Neuro-Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
Residency Program Director, Department of Neuro-Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX

Research Interests
Dr. Loghin’s research interests are focused on neurological complications related to cancer treatment, particularly neurological and cognitive deficits induced by cancer therapy. She is collaborating closely with the Neuropschylogy Section in developing new therapeutic strategies for cancer related cognitive dysfunction.

Honors & Awards
2011 Nominated for Gerald P. Bodey Award for Excellence in Education, University of Texas MD Anderson Cancer Center.

Giovanni Marchegiani is also a Course Mentor for Pancreas 2000 – EAC-CME accredited post-graduate educational program in Pancreatology at the Karolinska University – Stockholm and Assistant professor at the Verona University – Italy, School of Medicine – Elective Courses in General Surgery.

 Scientific Association Memberships and Positions

United European Gastroenterology (UEG) since 2017 – Elected Member of the UEG Quality of Care Task Force (2019-2022)

Italian Young Gastroenterologists and Endoscopists Society (AGGEI) since 2012, Member of the Surgical Commission

European Digestive Surgery (EDS) since 2012, Member of the executive council since 2014

European African Hepato-Pancreato-Biliary Association (EAHPBA) since 2013, Member of the Sucommittee on Educational Activities since 2015

International Hepato-Pancreato-Biliary Association (IHPBA) since 2013

Italian Association for the study of the Pancreas (AISP) since 2010

European Pancreas Club (EPC) since 2011

Clinical Robotic Surgical Association (CRSA) since 2012

American Pancreatic Association (APA) since 2013

The Pancreas Club (Pancreas Club, USA) since 2014

Società Medico Chirurgica Bologna (Bologna University, Italy) since 2015

 Awards

Best Student of the year 2005-2006 and 2006-2007 – Alma Mater Studiorum, University of Bologna, School of Medicine

American Pancreatic Association Young Investigator Travel Award 2013, APA annual meeting, Miami, USA

The Kenneth-Warren Research award for best oral presentation – The Pancreas Club 2014 meeting, Chicago, USA

EPC European Pancreas Club Best Oral Presentation in Clinical Science – EPC 2014 meeting, Southampton, UK

United European Gastroenterology Week UEGW Travel Award 2014 – UEGW 2014 meeting, Vienna, Austria

Società Medico Chirurgica Bologna – Professor Giovanni Mazzotti award for best anatomist of the year 2015 – Bologna University, Italy

Associazione Italiana Studio Pancreas AISP travel Award 2015 – AISP Meeting 2015

European Pancreatic Club Travel Grant Award 2016 – EPC 2016 Meeting, Liverpool, UK

EPC European Pancreas Club – Best young Paper in Pancreatology Award – EPC 2016 meeting, Liverpool, UK

The 2016 “Ettore Ruggeri” Award of the italian Surgical Society for the excellence in surgical research. Awarded for the research in the field of Intraductal Neoplasms of the Pancreas. SIC meeting 2016, Rome, Italy

EAHPBA Travel Grant Award – Best Young Paper at 12th Biennial EAHPBA Congress, 23-25 May 2017, Mainz, Germany

Dr. Vilca-Melendez graduated from the National University of San Marcos, in Lima-Peru.

In 1989, he started his specialization in experimental surgery and liver transplantation as a fellow of the Faculty of Medicine, University of Sao Paulo, Brazil, under the direction of Prof. Silvano Raia.

In 1993, he travelled to London, UK, to continue his clinical training in Liver Transplantation as a surgical registrar at King’s College Hospital.

In 2000; he was awarded the High Academic Degree of Doctor of Philosophy in Liver Transplantation by the University of London. After his PhD he has been actively involved in basic science research linked to liver transplantation and several clinical trials.

In 2001, he was promoted to Associate Specialist Surgeon and since 2007 he became Consultant Transplant Surgeon at King’s College Hospital. His current clinical duties involved adult and paediatric liver transplantation in one the largest liver transplant programmes worldwide (± 250 liver transplants a year).

In 2009, he was appointed the lead for a new service of Paediatric Intestinal Transplantation at King’s; with training in prestigious centers in the USA (Omaha, Miami and Chicago) and currently performing isolated small bowel, combined liver and bowel and multi-visceral transplantation with excellent results. In 2017, he performed successfully the first combined liver and small bowel transplant from a live donor in the UK and Europe in a 4-year old girl.

He is member of the Organ Donation and Intestinal Transplantation Advisory Groups for the organ transplantation national authority (NHSBT) and he is member of the British Transplantation Society (BTS), the European Society of Organ Transplantation (ESOT), the European Liver and Intestine Transplant Association (ELITA) and the International Pediatric Transplant Association (IPTA).

Paolo Muiesan graduated in Medicine at the University of Brescia (Italy). He continued his education as acting intern in University of California Davis, as resident in General Surgery and then further specialized in Vascular Surgery at the University of Milan. He trained in adult and pediatric liver transplantation and hepatobiliary surgery at King′s College Hospital in London. To complete his training in HPB Surgery and Liver Transplantation he visited the University of Nebraska Medical Center and the University of Western Ontario in 1996 and Kyoto University Transplant Centre in 1998.

He became Consultant Surgeon in HPB Surgery and Transplantation at King’s College Hospital in 1998 and moved to Birmingham Queen Elizabeth and Children’s Hospitals ten years later. He visited the Asan Medical Centre in Seoul in 2008 and 2009 in preparation to start the Living Donor Liver Transplant program in Birmingham and attended several courses on laparoscopic liver surgery. He became Professor in HPB Surgery and Transplantation at University of Birmingham in 2015. He is also Professor of General Surgery at the University of Florence and Director of Liver Surgery at Careggi Hospital

Professor Muiesan leads the living donor, auxiliary, domino and DCD liver transplantation programs in Birmingham. Other clinical and research interests include normothermic regional perfusion and machine perfusion as novel means of organ preservation for transplantation. His interests also include liver resections for cholangiocarcinoma, ALPPS and ex-situ, ante-situm liver resections.

He currently leads the surgical program for treatment of cholangiocarcinoma. Further interests include pancreatic resections with vascular involvement and Appleby procedures, open and laparoscopic, and radiofrequency ablation of primary and secondary liver tumors.

He served as Chair of the European Liver Intestine Transplant Association (ELITA) and Council Member of the European Society of Organ Transplantation (ESOT) from 2012 to 2015 and has been appointed Chair of the pediatric committee of the International Liver Transplantation Society (ILTS) and ILTS Council member in 2018. He joined by invitation the European Surgical Association in 2016. He has written 13 book chapters and is author/coauthor of over 220 publications.

Gabriel Oniscu graduated from the University of Medicine of Iasi, Romania. He has completed his surgical training in Edinburgh, Birmingham, King’s College Hospital, London and Assan Medical Centre Seoul and obtained a doctorate from the University of Edinburgh.

Mr. Oniscu is a consultant transplant surgeon at the Royal Infirmary of Edinburgh and Honorary Reader at the University of Edinburgh. He is involved in liver, kidney and pancreas transplantation and is the lead clinician for the living donor kidney transplant programme. He is also the led clinician for novel perfusion and preservation technologies in transplantation in Edinburgh.

He has a strong research activity with particular focus on transplant outcomes, organ perfusion and reconditioning and optical sensing. He is the recipient of the NRS Career Research Fellowship and an MRC confidence in concept award for technological developments relating to normothermic perfusion. Mr. Oniscu is associated with the Liver stem cells and regeneration research group at the Centre for Regenerative Medicine Edinburgh. He is a lead investigator in the NIHR Access to Transplantation and Transplant Outcomes study, the UK NHSBT service evaluation of normothermic regional perfusion in DCD donors and the MRC study investigating the regenerative capacity of liver ductular cells. He has received more than £4.5 mil in research funding.

Mr. Oniscu is Secretary of the European Society for Organ Transplantation and chairs the Research, Innovation and Novel Technologies Advisory Group at NHS Blood and Transplant.

He has authored more than 65 papers and 12 book chapters and is the editor of Abdominal Organ Retrieval and Transplantation Bench Surgery (Wiley) and Springer Atlas of Transplantation Surgery (in press).

National and international scientific societies: 

Romanian Society of Surgery: President 2006-2008;

Romanian Association of Transplantation (Romtransplant): President 1998- 2018;

Romanian Society of Endoscopic Surgery and other surgical techniques (ARCE): President 2002-2006;

Romanian Association of Hepato‐Biliary‐Pancreatic Surgery and Liver Transplantation: President 2006 – 2017;

European Surgical Association (ESA): Member (2007), President 2018-2019;

European Board of Surgery- Transplant Division (2009) and Hepato-Bilio-Pancreatic Surgery Division (2013);

European Society of Organ Transplantation (ESOT): Member;

International Association of Surgeons and Gastroenterologists (IASG): Member of Executive Committee (2002); Vice President- since 2016;

American College of Surgeons (FACS): Fellow (2005);

Romanian Academy of Medical Sciences Bucharest (Romania): Member (1999), President 2011-Present;

Romanian Academy: Corresponding Member (2013);

Federation of European Academies of Medicine (FEAM): Vice-president 2014- 2017;

Académie Nationale de Médecine France: Membre correspondant étranger ( 2013);

Académie Nationale de Chirurgie (France): Associe étranger (2003).

Editorial activities: Member of Editorial Board

Hepatogastroenterology: Editor-in-chief (2011-2012), Senior Honorary Editor ( 2013);

Chirurgia (Buc) (The Romanian Journal of Surgery): Editor-in-Chief (2004-2013);

Langenbeck’s Archives of Surgery: Associate Editor;

Journal of Gastrointestinal and Liver Disease: Member of the Editorial Board;

Surgery, Gastroenterology and Oncology: Vice-Editor in Chief.

Visiting Professor

Karolinska University in Stockholm (2010);

University of Belgrade, School of Medicine (2018).

Visiting Speaker

Grand Rounds AKH Vienna, “The surgical treatment of the metastatic colo-rectal cancer” (2015);

Universitätsklinikum Hamburg-Eppendorf- “Central pancreatectomy” (2015);

Weekly Surgical and Gastroenterological Grand Rounds- Borel-Staehelin-Lecture “How to increase the number of donors in a liver transplant program” – University of Zürich (2014).

Key Note Speaker

European Congress of Coloproctology: BJS lecture-“Metastatic CRC – what about the primary?”  Vienna (2012).

Background

Schiappa, Jose M. was born on August 30, 1944 in Lisbon, Portugal. Son of Artur F. and Maria L. Shiappa de Carvalho.

Education

Master of Science, Classic University Lisbon, 1971.

Career

Resident hospital Civis de Lisboa. Junior consultant St. Jame’s and St. George’s Hospital, London, 1972—1979. Assistant in surgery Hospital St. Antonio Capuchos, Lisbon, 1979—1994, chief surgery, since 1994.

Staff surgeon Hospital CUF Infante Santo, since 1994, director department surgery, since 2005. Chief editor Portugese Journal Surgery. General section European Academy Surgical Science.

Membership

Fellow: American College of Surgeons. Member: Lisbon Society Medical Sciences, Portuguese Society Gastroenterology, Portuguese Society Surgery, Pancreatic Society Great British and Ireland, Association European and Mediterranean Proctology, Royal Society Medicine, European Academy Sug. Sciences, Mediterranean Middle Eastern Surgical Association, International Association Surgeons and Gastroenterological, International Hepato Biliary Pancreatic Association, European Association Endoscopic Surgery.

General Surgeon, specialized in Digestive Surgery, Laparoscopic and Abdominal wall with main areas of interest in HBP Surgery, Colo-rectal surgery and Hernia surgery.
Working in the fields of Video-surgery, TEM/TEO (trans anal approach to rectal tumours) and Intraoperative Ultrasound
Also special interest in Education and Training and in New Technologies
Interest in the field of Video producing. Mainly scientific but also other areas

Member of Clinical direction of Hospital CUF Infante Santo from 1993 to 2005

Competence in Healthcare Units management obtained by the Portuguese Medical Association

Specialties: Introducer & co-introducer in Portugal of several New Techniques & Technologies
Pioneer of Laparoscopic Surgery in Portugal, Mini-laparoscopy (Laparoscopy performed w/ small diameter needles – “needlescopy”), Single port surgery, TEM (Transanal Endoscopic Microsurgery), Intraoperative Ultrasonography, Surgical tumour destruction by Radio-frequency, Choledocoscopy, Minimally invasive percutaneous trans hepatic techniques & HELP technique for the treatment of haemorrhoids w/ laser technology).

Laureato cum laude in Medicina e Chirurgia alla “Sapienza” di Roma).
Specialista cum laude in Chirurgia d’urgenza.
Specialista cum laude in Chirurgia vascolare.

Medico Chirurgo con all’attivo oltre 5000 interventi di  alta chirurgia.

Autore di oltre 400 pubblicazioni in estenso di cui 79 citate su Pubmed e coautore di un” Manuale di Medicina d’Urgenza” (Ed. CIC Roma 2011) e del vol. “Il chirurgo d’urgenza oggi” (ed. De Nicola Napoli 2000).

Presidente del Corso di Laurea in Infermieristica R  Polo Pontino “Sapienza” Roma dal 2005 al 2011.
Direttore della Scuola di Specializzazione in Chirurgia d’Urgenza e Pronto Soccorso dal 2001 al 2003.
Già Coordinatore del Master di I Livello di Infermiere di Area Critica “Sapienza” Sezione Polo Pontino.
Vice Direttore della Scuola di Specializzazione in Chirurgia Generale V  “Sapienza” Roma dal 2004 al 2014.
Coordinatore del Master di I livello in “Assistenza infermieristica in sala operatoria per la chirurgia specialistica-strumentistica”.
Direttore dal 2005 al 2015 della U.O.C. Universitaria di Chirurgia Generale e d’Urgenza – Polo Pontino “Sapienza” Università di Roma.
Direttore dal 2008 l 2015 del Dipartimento di Area Chirurgica POC AUSL Latina.
Presidente della Società Italiana di Chirurgia d’Urgenza e del Trauma.
Presidente dell’Associazione Culturale Forum Accademico di Formazione.
Presidente dell’Associazione Culturale Il Glicine.

MD, PhD, FRCP (London), Professor of gastroenterology and internal medicine at University of Medicine and Pharmacy “Grigore T. Popa” Iasi, Romania, Fellow of Academy of Medical Sciences, Fellow of Romanian Academy is one of the main founders of gastroenterology, diagnostic and therapeutic endoscopy in Romania.

He is former President of the University of Medicine and Pharmacy “Gr. T. Popa” Iasi (1992-2004), Dean of Faculty of Medicine (2004-2008), President of Romanian Society of Endoscopy (1996-2000), President of Romanian Society of Gastroenterology and Hepatology (2000-2008),Chairman Ethics Committee World Organization of Gastroenterology (1994-2002).

He has always been involved in all areas of academic life: medical training, especially therapeutic endoscopy, research in different areas (gastrointestinal motility, viral hepatitis, etc.), patient care, administrative work and mentorship. He received many awards from Romanian Presidency, French Presidency, WGO, Romanian Society of Gastroenterology and Hepatology and many universities.

Dr. Kyoichi Takaori is a pancreatic surgeon who has extensive experiences of open, laparoscopic, and robotic surgery. His academic career includes Professor of Surgery at Asahi University and Assistant Professor of Physiology and Biophysics at University of Arkansas for Medical Sciences. Thorough his career as a surgeon, he has struggled to improve the prognosis of pancreatic cancer, which is known as the worst malignancy. First, he has focused on early detection of pancreatic cancer so that surgeons can offer truly curative operations to the patients. In 2003, with Dr. Ralph Hruban, Dr. Takaori organized International Expert Meeting on Precursor Lesions of Pancreatic Cancer and created international consensus on the classification of pancreatic intraepithelial neoplasia (PanIN) and intraductal papillary mucinous neoplasm (IPMN). World Health Organization has adopted this classification system, which helps investigators better understand the precursor lesions.  Furthermore, in pursuit of early diagnosis and treatment of pancreatic cancer in high-risk individuals, he has founded a Japanese Familial Pancreatic Cancer Registry and is promoting collateral studies as the chairman of the registry committee of Japan Pancreas Society. Second, he has endeavored to improve the surgical techniques for pancreatic malignancies. In order to improve local control and to perform more oncologic resections, he has refined artery-first pancreatoduodenectomy and developed new techniques of artery-first distal pancreatectomy, and artery-first DP-CAR by utilizing the “Tiger’s Den” approach in all open, laparoscopic and robotic surgery. Third, he is a great believer of multi-disciplinary approach and presently directing the multi-disciplinary team as the Head of Pancreatic Cancer Unit at Kyoto University Hospital. Recently, he has conducted international collaborative study on the clinical managements of pancreatic cancer. Last but not least, Dr. Takaori has served patient’s activities on the Medical Advisory Board for PanCAN Japan and the Scientific Advisory Board for Pancreatic Cancer UK. He is Founding Editor of Surgery, Gastroenterology and Oncology, the official journal of the International Association of Surgeons, Gastroenterologists and Oncologists (IASGO), and has served Pancreatology also as the Vice Editor-in-Chief of Pancreatology for over eight years. Along with Prof. Dan Duda, Prof. Takaori is organizing IASGO World Congresses as well as many Postgraduate Courses for the purpose of “Globalization of Medical Knowledge” all over the world.

MD, PhD, FEBGH, FRCP (London) is Professor of Gastroenterology and Internal Medicine at University of Medicine and Pharmacy “Grigore. T. Popa”, Iasi, Romania where she serves as Director of Department of Internal Medicine, Gastroenterology and Cardiology and chief of IInd Clinic of Gastroenterology “St. Spiridon” Hospital.

She has been between 2019-2019 the President of the Romanian Society of Gastroenterology and Hepatology, the representative of Romania for UEG Forum of members, member of the Board of European Exam of Gastroenterology.

She has been involved in the medical teaching from the beginning of her career. She received many prizes from scientific organizations (e.g., Rising Stars in Gastroenterology awarded by UEG).

Nikola Vladov is the head of the HPB and Transplant Surgery and the leading surgeon there. He has numerous specializations on HPB surgery and liver transplantation in the most important Parisian HPB hospitals – Cochin Hospital, Saint Antoine Hospital and Beaujon Hospital in the period from 1995 till present. Three scientific bularian-french surgical meetings were performed in his department including state of the art lectures and live demonstrations, due to close collaboration with French liver surgeons. These yearly performed postgraduate courses have been subsequently held under the auspices of IASGO in the following years. On the other hand, the department of prof. Vladov has become a preferred place for postgraduate specialization in surgery in Bulgaria. From 2018 his department has endorsed as centre of excellence for laparoscopic HPB surgery. He is a pioneer in the development of laparoscopic HPB surgery in Bulgaria – first laparoscopic liver resection in 2005, first laparoscopic distal spleno-pancreatectomy – 2006, first laparoscopic major hepatectomy combined with colorectal resection in 2014. Concerning the field of transplantation, he performed first adult to adult living donor liver transplantation in Bulgaria (2009) as well as the first re-transplantation of the liver (2013). Prof. Vladov is the author of more than four hundred scientific publications. He collaborated in many international clinical trials for CRC liver metastases, HCC and Pancreatic Cancer. He was elected for foreign member of the French Academy of Surgery in 2013 year. He is the President of the Bulgarian Transplant Society and long-lasting member of IASGO. Nowadays he is among the founding members of the International Laparoscopic Liver Society.